Boneview-ED - Impact of Artificial Intelligence Detecting Fractures in the Emergence Department : a Pragmatic Prospective Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Angers

About this trial

Traumatic emergencies are the primary reason for consultation in emergency departments and standard radiography is the primary imaging exam for osteoarticular trauma. However, with the increase in the number of patients admitted to emergency departments and thus the increased workload for emergency room attendants, Interpretation of radiographs in trauma emergencies is made more difficult, resulting in a high risk of misinterpretation.

The growing presence of artificial intelligence in the medical field, notably through the involvement of diagnostic software on imageries, makes its use more relevant in the aid of the replay of osteoarticular imageries.

A recent meta-analysis of 32 studies evaluating the performance of artificial intelligence in fracture detection found comparable performance between experienced radiologists and AI-based diagnosis. However, these were mainly retrospective studies, and thus more distant from the reality of its use in a care stream such as emergencies.

The objective of this study is therefore to prospectively validate the use of artificial intelligence software during its implementation in an emergency department for patients admitted for a suspicion of osteoarticular trauma.

Eligibility criteria

Qualifiers

Major patient

Admitted to the emergency department after trauma less than 48 hours

Patient with an indication on an x-ray of the limbs or/and pelvis

Express patient consent

Disqualifiers

Polytraumatized patient

X-ray of the corso-lumbar spine, skull, cervical spine (all parts of the body not affected by the intended use of the software)

Pregnant, lactating or parturient patient

Trial design

Treatments tested in this trial

  • processing the radiography with the "Boneview" software

Treatment groups

1,600 Participants
are divided into 1 treatment group

Sponsors and collaborators